Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes.
Sommerfield
Andrew J
AJ
Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh EH16 4ES, Scotland, U.K.
Deary
Ian J
IJ
Frier
Brian M
BM
D000208:Acute Disease; D017677:Age Distribution; D000368:Aged; D000704:Analysis of Variance; D001786:Blood Glucose / Q000032:analysis; D003072:Cognition Disorders / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D009483:Neuropsychological Tests; D011336:Probability; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution
D001786:Blood Glucose; D007004:Hypoglycemic Agents